![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 29, 26225-26232, July 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-mediated Apoptotic
Response*
§,
§,
,
,
,
,
,
,
, and
**
From the BRCA1 is a tumor suppressor gene implicated in
transcriptional regulation. We have generated cell lines with inducible
expression of BRCA1 as a tool to identify downstream targets that may
be important mediators of BRCA1 function. Oligonucleotide array-based expression profiling identified 11 previously described interferon regulated genes that were up-regulated following inducible expression of BRCA1. Northern blot analysis revealed that a subset of the identified targets including IRF-7, MxA, and ISG-54 were
synergistically up-regulated by BRCA1 in the presence of interferon
Department of Oncology, Cancer Research
Centre, The Queen's University Belfast, Belfast BT9 7AB, Northern
Ireland, the ¶ Department of Medicine, University of North
Carolina, Chapel Hill, North Carolina 27599, and the
Massachusetts General Hospital Cancer Center and Harvard Medical
School, Charlestown, Massachusetts 02129
(IFN-
) but not interferons
or
. Importantly, IFN-
-mediated
induction of IRF-7 and MxA was attenuated in the BRCA1 mutant cell line HCC1937, an effect that was rescued following reconstitution of exogenous wild type BRCA1 in these cells. Furthermore, reconstituted BRCA1 sensitized HCC1937 cells to IFN-
-induced apoptotic cell death. This study identifies BRCA1 as a component of the
IFN-
-regulated signaling pathway and suggests that BRCA1 may play a
role in the regulation of IFN-
-mediated apoptosis.
This article has been cited by other articles:
![]() |
A. M. Hosey, J. J. Gorski, M. M. Murray, J. E. Quinn, W. Y. Chung, G. E. Stewart, C. R. James, S. M. Farragher, J. M. Mulligan, A. N. Scott, et al. Molecular Basis for Estrogen Receptor {alpha} Deficiency in BRCA1-Linked Breast Cancer J Natl Cancer Inst, November 21, 2007; 99(22): 1683 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Buckley, A. M. Hosey, J. J. Gorski, J. W. Purcell, J. M. Mulligan, D. P. Harkin, and P. B. Mullan BRCA1 Regulates IFN-{gamma} Signaling through a Mechanism Involving the Type I IFNs Mol. Cancer Res., March 1, 2007; 5(3): 261 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Bean, C. Ibarra Drendall, V. K. Goldenberg, J. C. Baker Jr., M. M. Troch, C. Paisie, L. G. Wilke, L. Yee, P. K. Marcom, B. F. Kimler, et al. Hypermethylation of the Breast Cancer-Associated Gene 1 Promoter Does Not Predict Cytologic Atypia or Correlate with Surrogate End Points of Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 50 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. DelloRusso, P. L. Welcsh, W. Wang, R. L. Garcia, M.-C. King, and E. M. Swisher Functional Characterization of a Novel BRCA1-Null Ovarian Cancer Cell Line in Response to Ionizing Radiation Mol. Cancer Res., January 1, 2007; 5(1): 35 - 45. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Kennedy, J. J. Gorski, J. E. Quinn, G. E. Stewart, C. R. James, S. Moore, K. Mulligan, E. D. Emberley, T. F. Lioe, P. J. Morrison, et al. BRCA1 and c-Myc Associate to Transcriptionally Repress Psoriasin, a DNA Damage-Inducible Gene Cancer Res., November 15, 2005; 65(22): 10265 - 10272. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mitra-Kaushik, J. Harding, J. Hess, R. Schreiber, and L. Ratner Enhanced tumorigenesis in HTLV-1 Tax-transgenic mice deficient in interferon-gamma Blood, November 15, 2004; 104(10): 3305 - 3311. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Gilmore, N. McCabe, J. E. Quinn, R. D. Kennedy, J. J. Gorski, H. N. Andrews, S. McWilliams, M. Carty, P. B. Mullan, W. P. Duprex, et al. BRCA1 Interacts with and Is Required for Paclitaxel-Induced Activation of Mitogen-Activated Protein Kinase Kinase Kinase 3 Cancer Res., June 15, 2004; 64(12): 4148 - 4154. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bai and J. L. Merchant Transcription factor ZBP-89 is required for STAT1 constitutive expression Nucleic Acids Res., December 15, 2003; 31(24): 7264 - 7270. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Quinn, R. D. Kennedy, P. B. Mullan, P. M. Gilmore, M. Carty, P. G. Johnston, D. P. Harkin, U. Benatti, L. C. Boffa, and M. Ferrarini BRCA1 Functions as a Differential Modulator of Chemotherapy-induced Apoptosis Cancer Res., October 1, 2003; 63(19): 6221 - 6228. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |